Abbott Laboratories

Abbott Laboratories Beats on EPS, Stock Down 0.6%

Abbott Laboratories reported an EPS of $1.17, exceeding expectations by 16.19%. However, the stock reacted negatively, declining by 0.6%. This suggests that despite the earnings beat, investors may have had concerns about other aspects of the company's performance or future outlook.